These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23012121)

  • 21. Clinical case management and navigation for colonoscopy screening in an academic medical center.
    Cavanagh MF; Lane DS; Messina CR; Anderson JC
    Cancer; 2013 Aug; 119 Suppl 15():2894-904. PubMed ID: 23868484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Colorectal cancer screening: facts and questions].
    Faivre J; Dancourt V
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B86-93. PubMed ID: 12068275
    [No Abstract]   [Full Text] [Related]  

  • 23. Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks.
    Lane DS; Messina CR; Cavanagh MF; Anderson JC
    Cancer; 2013 Aug; 119 Suppl 15():2842-8. PubMed ID: 23868478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality assurance in colonoscopy for colorectal cancer diagnosis.
    Macken E; Moreels T; Vannoote J; Siersema PD; Van Cutsem E
    Eur J Surg Oncol; 2011 Jan; 37(1):10-5. PubMed ID: 20951537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Colonoscopy for early detection and prevention of colorectal cancer].
    Niv Y
    Harefuah; 2010 Aug; 149(8):535-6, 549. PubMed ID: 21341435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New European initiatives in colorectal cancer screening: Budapest Declaration. Official appeal during the Hungarian Presidency of the Council of the European Union under the Auspices of the United European Gastroenterology Federation, the European Association for Gastroenterology and Endoscopy and the Hungarian Society of Gastroenterology.
    Wittmann T; Stockbrugger R; Herszényi L; Jonkers D; Molnár B; Saurin JC; Regula J; Malesci A; Laghi L; Pintér T; Teleky B; Dítě P; Tulassay Z
    Dig Dis; 2012; 30(3):320-2. PubMed ID: 22722559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 29. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
    Rozen P; Shabtai EI; Liphshitz I; Barchana M
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening in an expanding panorama of screening programmes.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of technology overlapping: a case study on colorectal cancer screening.
    Di Bidino R; Cicchetti A; Corio M; Polisena J; Oradei M; Marchetti M
    Technol Health Care; 2010; 18(4-5):303-15. PubMed ID: 21209479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Colorectal cancer screening programs in the population at average risk in the European Union and Spain].
    Grau J; Serradesanferm A; Polbach S; García-Basteiro AL; Trilla A; Castells A
    Gastroenterol Hepatol; 2010 Feb; 33(2):111-8. PubMed ID: 19523716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementing Colorectal Cancer Screening: Group 2 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003.
    Rozen P; Blanchard J; Campbell D; Carlsen E; Lambert R; Marbet U; Peterson K; Regula J; Segnan N; Suchanek S; Van Gossum A
    Endoscopy; 2004 Apr; 36(4):354-8. PubMed ID: 15057690
    [No Abstract]   [Full Text] [Related]  

  • 36. Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions.
    Vieth M; Quirke P; Lambert R; von Karsa L; Risio M
    Virchows Arch; 2011 Jan; 458(1):21-30. PubMed ID: 21061132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Colorectal neoplasm, screening and pluralism].
    Hadengue A
    Rev Med Suisse; 2010 Sep; 6(261):1635-6. PubMed ID: 20939395
    [No Abstract]   [Full Text] [Related]  

  • 39. Choice of screening modality in a colorectal cancer education and screening program for the uninsured.
    Sarfaty M; Feng S
    J Cancer Educ; 2006; 21(1):43-9. PubMed ID: 16918290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.